FMP
NASDAQ
62.24 USD
1.78 (2.86%)
Mr. Brian A. Markison
Healthcare
Drug Manufacturers - Specialty & Generic
https://www.lantheus.com
NASDAQ
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors. The company also of...
0001521036
US5165441032
516544103
331 Treble Cove Road
978 671 8001
US
834
Jun 25, 2015
0001521036
NASDAQ
Drug Manufacturers -...
Healthcare
516544103
US5165441032
US
62.24
0.55
1.15M
4.27B
-
50.2-100.851
94.5
-
-
-
-
13.38
-
https://www.lantheus.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.